VUV PROPERTIES OF Eu3+- DOPED YBO3 PHOSPHOR PREPARED VIA ALDO-KETO AND SOLID-STATE PROCESS

The Eu3+ doped YBO3 was prepared by the novel aldo-keto method. The structure and VUV luminescence properties of the title compound were studied and compared to the corresponding properties of the materials prepared by a conventional solid state reaction. The use of novel aldo-keto method in preparation lowered the reaction threshold temperature by c.a. 300oC. The YBO3 phosphor from the aldo-keto method look like evenly sized spherical structures, whereas those from the solid-state process look like some agglomerates of little spheres. The Eu3+-doped YBO3 phosphors prepared by both methods showed the red emission with peak around 592, 611 and 627 nm at excitations wavelengths 147 and172 nm, which corresponds to the transitions from the excited 5D0 level to the 7FJ (J = 1, 2, 3, 4) levels of Eu3+ activators. However, the emission intensity of the Eu3+ doped YBO3 from the aldo-keto system is about 2 times as much as that from the sold-state process

Regional Variations in Emergency Service Performance: Does Social Capital Matter?

Regional variations in emergency service performance: does social capital matter?, Regional Studies. The relationship between social capital and the performance of public organizations is currently at the top of the UK policy agenda and elsewhere. This paper examines whether social capital is associated with improved regional emergency service performance by exploring its relationship with the achievements of ambulance trusts in England. Drawing on a six-year panel dataset, ambulance response times are modelled using an index of social capital, incorporating measures of community organizational life, political efficacy and social trust, in the regions served by National Health Service (NHS) ambulance trusts. Theoretical and practical implications are discussed

General anaesthetic and airway management practice for obstetric surgery in England: a prospective, multi-centre observational study

There are no current descriptions of general anaesthesia characteristics for obstetric surgery, despite recent changes to patient baseline characteristics and airway management guidelines. This analysis of data from the direct reporting of awareness in maternity patients' (DREAMY) study of accidental awareness during obstetric anaesthesia aimed to describe practice for obstetric general anaesthesia in England and compare with earlier surveys and best-practice recommendations. Consenting patients who received general anaesthesia for obstetric surgery in 72 hospitals from May 2017 to August 2018 were included. Baseline characteristics, airway management, anaesthetic techniques and major complications were collected. Descriptive analysis, binary logistic regression modelling and comparisons with earlier data were conducted. Data were collected from 3117 procedures, including 2554 (81.9%) caesarean deliveries. Thiopental was the induction drug in 1649 (52.9%) patients, compared with propofol in 1419 (45.5%). Suxamethonium was the neuromuscular blocking drug for tracheal intubation in 2631 (86.1%), compared with rocuronium in 367 (11.8%). Difficult tracheal intubation was reported in 1 in 19 (95%CI 1 in 16-22) and failed intubation in 1 in 312 (95%CI 1 in 169-667). Obese patients were over-represented compared with national baselines and associated with difficult, but not failed intubation. There was more evidence of change in practice for induction drugs (increased use of propofol) than neuromuscular blocking drugs (suxamethonium remains the most popular). There was evidence of improvement in practice, with increased monitoring and reversal of neuromuscular blockade (although this remains suboptimal). Despite a high risk of difficult intubation in this population, videolaryngoscopy was rarely used (1.9%)

Verrucous hemangioma and histopathological differential diagnosis with angiokeratoma circumscriptum neviforme

Verrucous hemangioma is a rare vascular skin disorder with an immune profile similar to vascular neoplasms, but with behavior and evolution of vascular malformations. Its main differential diagnosis is angiokeratoma circumscriptum neviforme, with an almost indistinguishable clinical presentation because both diseases appear as erythematous patches that evolve to violaceous plaques, becoming scaly and even verrucous, most commonly affecting the lower limbs. Histopathology is crucial for the correct diagnosis: while in angiokeratoma the vascular alterations are limited to the papillary dermis, verrucous hemangioma extends deep into the dermis, reaching the subcutaneous tissue

Influence of elevated CO2 on growth, yield, haulm, and kernel quality of groundnut (Arachis hypogaea L.)

A study was conducted to evaluate the effect of elevated CO2 on groundnut growth, yield, kernel and haulm nutritional quality in the Open Top Chambers (OTC). Three regimes of CO2, ambient (380 ppm) and two elevated CO2 levels (550 and 700 ppm) are maintained in three different OTCs. Compared to the ambient CO2 conditions, the kernel yield per plant declined by 32.28% and 28.40% at 550 and 700 ppm, respectively, although the pod yield remained unaffected under elevated CO2. Under elevated CO2, plant height, specific leaf area, root area and root volume are reduced, while specific leaf weight increased because of leaf thickening. Root dry weight increased due to allocation of extra fixed carbon to roots for greater support to growth under CO2 enriched conditions. Haulm quality is reduced under elevated CO2, observed as reduced metabolizing energy and in-vitro organic matter digestibility at 550 ppm, and low ash and nitrogen content at 700 ppm. Kernel oil (6.54% and 2.98%) and protein content (7.07% and 4.56%) declined at 550 and 700 ppm as compared to ambient conditions, while fatty acid content remained unaffected. Among minerals, kernel iron and manganese content remained unaffected, while copper (13.93% and 26.19%) and calcium (24.33% and 8.20%) content declined at both elevated CO2 levels. The genotype by trait biplot analysis revealed ICGV 03043 as the best performing genotype with a superior trait profile alongside high kernel yield and oil content across three CO2 levels, making it a candidate for future studies to understand the insensitivity to elevated CO2

Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.

Three homologues of TGF-β exist in mammals as follows: TGF-β1, TGF-β2, and TGF-β3. All three proteins share high homology in their amino acid sequence, yet each TGF-β isoform has unique heterologous motifs that are highly conserved during evolution. Although these TGF-β proteins share similar properties in vitro, isoform-specific properties have been suggested through in vivo studies and by the unique phenotypes for each TGF-β knock-out mouse. To test our hypothesis that each of these homologues has nonredundant functions, and to identify such isoform-specific roles, we genetically exchanged the coding sequence of the mature TGF-β1 ligand with a sequence from TGF-β3 using targeted recombination to create chimeric TGF-β1/3 knock-in mice (TGF-β1(Lβ3/Lβ3)). In the TGF-β1(Lβ3/Lβ3) mouse, localization and activation still occur through the TGF-β1 latent associated peptide, but cell signaling is triggered through the TGF-β3 ligand that binds to TGF-β receptors. Unlike TGF-β1(−/−) mice, the TGF-β1(Lβ3/Lβ3) mice show neither embryonic lethality nor signs of multifocal inflammation, demonstrating that knock-in of the TGF-β3 ligand can prevent the vasculogenesis defects and autoimmunity associated with TGF-β1 deficiency. However, the TGF-β1(Lβ3/Lβ3) mice have a shortened life span and display tooth and bone defects, indicating that the TGF-β homologues are not completely interchangeable. Remarkably, the TGF-β1(Lβ3/Lβ3) mice display an improved metabolic phenotype with reduced body weight gain and enhanced glucose tolerance by induction of beneficial changes to the white adipose tissue compartment. These findings reveal both redundant and unique nonoverlapping functional diversity in TGF-β isoform signaling that has relevance to the design of therapeutics aimed at targeting the TGF-β pathway in human disease